Pipradrol

Pipradrol is federally controlled in the United States as a Schedule IV stimulant under 21 C.F.R. § 1308.14(f)(10), including its salts, isomers, salts of isomers, and any material, compound, mixture, or preparation containing any quantity, unless specifically excepted or listed in another schedule. Federal control took effect on 1 December 1980. Its manufacture, distribution, dispensing, possession with intent to manufacture, distribute, or dispense, and possession are prohibited unless federally authorized; possession is permitted when obtained directly or under a valid prescription or order from a practitioner acting in professional practice, or when otherwise authorized. Importation and exportation are restricted to authorized medical, scientific, or other legitimate uses and are subject to applicable federal notification or declaration requirements, with exports also requiring advance proof that importation is lawful in the destination country.

Pipradrol is a Class C drug under Schedule 2, Part III of the Misuse of Drugs Act 1971, with its control in force since 1 July 1973. Possession, production, supply, offering to supply, possession with intent to supply, importation and exportation are prohibited, subject to statutory regulations, licences, authorities, exceptions and defences. The maximum penalty on indictment is two years' imprisonment, a fine or both for possession, and fourteen years' imprisonment, a fine or both for production, supply, offering to supply or possession with intent to supply.